Cullinan Associates Inc. Acquires 1,307 Shares of CME Group Inc. (NASDAQ:CME)

Cullinan Associates Inc. grew its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 7.4% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 18,954 shares of the financial services provider's stock after acquiring an additional 1,307 shares during the quarter. Cullinan Associates Inc.'s holdings in CME Group were worth $5,028,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the business. Intact Investment Management Inc. bought a new stake in shares of CME Group in the first quarter valued at about $80,000. Weaver Capital Management LLC boosted its position in shares of CME Group by 3.1% in the first quarter. Weaver Capital Management LLC now owns 2,944 shares of the financial services provider's stock valued at $781,000 after acquiring an additional 88 shares during the period. World Equity Group Inc. bought a new stake in shares of CME Group in the first quarter valued at about $228,000. Stonegate Investment Group LLC boosted its position in shares of CME Group by 6.7% in the first quarter. Stonegate Investment Group LLC now owns 1,463 shares of the financial services provider's stock valued at $388,000 after acquiring an additional 92 shares during the period. Finally, Perfromance Wealth Partners LLC boosted its position in shares of CME Group by 0.5% in the first quarter. Perfromance Wealth Partners LLC now owns 11,329 shares of the financial services provider's stock valued at $3,005,000 after acquiring an additional 57 shares during the period. Institutional investors own 87.75% of the company's stock.

Analyst Ratings Changes

CME has been the subject of several recent analyst reports. Royal Bank Of Canada reaffirmed a "sector perform" rating and set a $269.00 price objective on shares of CME Group in a research report on Thursday, April 3rd. Barclays boosted their target price on CME Group from $279.00 to $283.00 and gave the stock an "equal weight" rating in a research note on Wednesday, April 23rd. UBS Group boosted their target price on CME Group from $290.00 to $305.00 and gave the stock a "buy" rating in a research note on Friday, April 25th. Piper Sandler boosted their target price on CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a research note on Tuesday, April 8th. Finally, Morgan Stanley boosted their target price on CME Group from $301.00 to $304.00 and gave the stock an "overweight" rating in a research note on Thursday, April 24th. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $258.20.

Insider Buying and Selling at CME Group

In other CME Group news, Director Charles P. Carey sold 500 shares of the stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $265.35, for a total transaction of $132,675.00. Following the completion of the sale, the director now owns 4,900 shares of the company's stock, valued at approximately $1,300,215. This represents a 9.26% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Derek Sammann sold 4,650 shares of the stock in a transaction that occurred on Monday, May 5th. The shares were sold at an average price of $280.61, for a total transaction of $1,304,836.50. Following the sale, the insider now directly owns 8,336 shares of the company's stock, valued at $2,339,164.96. This represents a 35.81% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 13,400 shares of company stock valued at $3,680,610. 0.30% of the stock is currently owned by company insiders.

CME Group Stock Performance

CME Group stock opened at $273.99 on Friday. The business has a 50 day moving average of $274.17 and a 200-day moving average of $255.51. CME Group Inc. has a 1 year low of $192.11 and a 1 year high of $290.79. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market capitalization of $98.73 billion, a P/E ratio of 27.56, a P/E/G ratio of 3.72 and a beta of 0.45.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.61 by $0.19. The company had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a return on equity of 14.03% and a net margin of 57.71%. The firm's revenue was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.50 earnings per share. On average, equities research analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.82%. The ex-dividend date of this dividend is Monday, June 9th. CME Group's dividend payout ratio is presently 50.30%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.